Hershey Trust Co Buys Snap Inc, CRISPR Therapeutics AG, AbbVie Inc, Sells The Hershey Co, Momo Inc, Clovis Oncology Inc

• New Purchases: SNAP, CRSP, ABBV, COUP, SAGE,
• Added Positions: GBT, MYOK,
• Reduced Positions: HSY,
• Sold Out: MOMO, CLVS, WUBA, EDIT, NOAH, VYGR,

For the details of HERSHEY TRUST CO's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=HERSHEY+TRUST+CO

1. The Hershey Co (HSYFB) - 60,612,012 shares, 87.92% of the total portfolio.
2. The Hershey Co (HSY) - 8,253,521 shares, 11.97% of the total portfolio. Shares reduced by 35.28%
3. Vipshop Holdings Ltd (VIPS) - 168,410 shares, 0.02% of the total portfolio.
4. Global Blood Therapeutics Inc (GBT) - 54,010 shares, 0.02% of the total portfolio. Shares added by 29.60%
5. Snap Inc (SNAP) - 93,156 shares, 0.02% of the total portfolio. New Position

Hershey Trust Co initiated holdings in Snap Inc. The purchase prices were between $11.83 and $17.59, with an estimated average price of $14.52. The stock is now traded at around $14.81. The impact to the portfolio due to this purchase was 0.02%. The holdings were 93,156 shares as of 2017-09-30.

Hershey Trust Co initiated holdings in CRISPR Therapeutics AG. The purchase prices were between $15.78 and $20.66, with an estimated average price of $18.1. The stock is now traded at around $19.53. The impact to the portfolio due to this purchase was 0.01%. The holdings were 42,991 shares as of 2017-09-30.

Hershey Trust Co initiated holdings in Sage Therapeutics Inc. The purchase prices were between $61.4 and $88.52, with an estimated average price of $78.82. The stock is now traded at around $62.41. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 1,887 shares as of 2017-09-30.

Hershey Trust Co initiated holdings in Coupa Software Inc. The purchase prices were between $29.03 and $32.11, with an estimated average price of $30.46. The stock is now traded at around $35.70. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 1,851 shares as of 2017-09-30.

Hershey Trust Co initiated holdings in AbbVie Inc. The purchase prices were between $69.85 and $89.22, with an estimated average price of $76.06. The stock is now traded at around $92.26. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 1,569 shares as of 2017-09-30.

Hershey Trust Co added to the holdings in MyoKardia Inc by 26.04%. The purchase prices were between $13.05 and $48.7, with an estimated average price of $31.44. The stock is now traded at around $36.90. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 20,064 shares as of 2017-09-30.

Hershey Trust Co added to the holdings in Global Blood Therapeutics Inc by 29.60%. The purchase prices were between $25.1 and $30.4, with an estimated average price of $28.09. The stock is now traded at around $32.60. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 54,010 shares as of 2017-09-30.

Hershey Trust Co sold out the holdings in Momo Inc. The sale prices were between $32.44 and $45.99, with an estimated average price of $39.81.

Hershey Trust Co sold out the holdings in Clovis Oncology Inc. The sale prices were between $67.17 and $98.02, with an estimated average price of $79.45.

Hershey Trust Co sold out the holdings in 58.com Inc. The sale prices were between $43.46 and $68, with an estimated average price of $56.53.

Hershey Trust Co sold out the holdings in Voyager Therapeutics Inc. The sale prices were between $8.24 and $19.53, with an estimated average price of $11.11.

Hershey Trust Co sold out the holdings in Editas Medicine Inc. The sale prices were between $15.45 and $23.16, with an estimated average price of $18.93.

Hershey Trust Co sold out the holdings in Noah Holdings Ltd. The sale prices were between $26.91 and $32.84, with an estimated average price of $30.46.